Davita - Prairie River Dialysis is a medicare approved dialysis facility center in Merrill, Wisconsin and it has 6 dialysis stations. It is located in Lincoln county at 601 S Center Ave, Merrill, WI, 54452. You can reach out to the office of Davita - Prairie River Dialysis at (715) 539-0613. This dialysis clinic is managed and/or owned by Davita. Davita - Prairie River Dialysis has the following ownership type - Profit. It was first certified by medicare in October, 2009. The medicare id for this facility is 522585 and it accepts patients under medicare ESRD program.
Name | Davita - Prairie River Dialysis |
---|---|
Location | 601 S Center Ave, Merrill, Wisconsin |
No. of Dialysis Stations | 6 |
Medicare ID | 522585 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | Yes |
601 S Center Ave, Merrill, Wisconsin, 54452 | |
(715) 539-0613 | |
Not Available |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
NPI Number | 1821387176 |
Organization Name | Prairie River Dialysis |
Doing Business As | Total Renal Care Inc |
Address | 601 S Center Ave Merrill, Wisconsin, 54452 |
Phone Number | (715) 539-0613 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
Dialysis patients with Hemoglobin data | 8 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 17 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 134 |
Percentage of adult patients getting regular hemodialysis at the center | 94 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Prairie River Dialysis with elevated calcium levels.
Patients with hypercalcemia | 20 |
Hypercalcemia patient months | 166 |
Patients with Serumphosphor | 22 |
Patients with Serumphosphor less than 3.5 mg/dL | 3 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 36 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 17 |
Patients with Serumphosphor greater than 7 mg/dL | 20 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 14 |
Patient months included in arterial venous fistula and catheter summaries | 86 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 73 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 18 |
Hospitalization Rate in facility | 211.1 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 523.7 |
Hospitalization Rate: Lower Confidence Limit | 91.4 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Prairie River Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 37.7 (As Expected) |
Readmission Rate: Upper Confidence Limit | 56.2 |
Readmission Rate: Lower Confidence Limit | 22 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Prairie River Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | 2.72 (As Expected) |
SIR: Upper Confidence Limit | 7.4 |
SIR: Lower Confidence Limit | .69 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Prairie River Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 14 |
Transfusion Rate in facility | (Not Available) |
Transfusion Rate: Upper Confidence Limit | |
Transfusion Rate: Lower Confidence Limit |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Prairie River Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 94 |
Mortality Rate in facility | 21.6 (As Expected) |
Mortality Rate: Upper Confidence Limit | 33 |
Mortality Rate: Lower Confidence Limit | 13.4 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago
Davita - Prairie River Dialysis Location: 601 S Center Ave, Merrill, Wisconsin, 54452 Phone: (715) 539-0613 |
News Archive
Celldex Therapeutics, Inc. today announced the presentation of mature overall survival (OS) data for ACT III, a multi-center, single arm, Phase 2 clinical trial of rindopepimut (CDX-110) in patients with newly diagnosed EGFRvIII-positive glioblastoma (GB).
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
Even cells aren't immune to peer pressure. Scientists at the Stanford University School of Medicine have now shown that skin cells can be coaxed to behave like muscle cells - and muscle cells like skin cells - solely by altering who they hang out with: the relative levels of the ingredients inside the cell.
A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.
DRX, a leading provider of healthcare comparison tools, technology and data, today announced that over 10 million beneficiaries have been enrolled in a Medicare plan using the DRX's licensed online suite of PlanCompare tools for drug and health plan comparison and enrollment.
› Verified 1 days ago